What development phase is P-Chlorophenoxyacetylpiperonylpiperazide in?

P-Chlorophenoxyacetylpiperonylpiperazide is FDA-approved (marketed).

What is the generic name of P-Chlorophenoxyacetylpiperonylpiperazide?

FIPEXIDE is the generic (nonproprietary) name of P-Chlorophenoxyacetylpiperonylpiperazide.

Last reviewed 2026-04-20 · How we verify

P-Chlorophenoxyacetylpiperonylpiperazide (FIPEXIDE)

FDA-approved withdrawn Small molecule Quality 6/100

At a glance

Generic name	FIPEXIDE
Drug class	fipexide
Modality	Small molecule
Therapeutic area	Neuroscience
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

P-Chlorophenoxyacetylpiperonylpiperazide CI brief — competitive landscape report
P-Chlorophenoxyacetylpiperonylpiperazide updates RSS · CI watch RSS